Member Info for Thompi

Or equally Si, in my case, the day after I sell :)
It’s uncanny how if I sell the price shoots up and vice versa if I buy. It’s a talent…..an unwanted one!

Can’t argue with that Trunky.

I agree Sajy, the directors buying after the CRL was a big demonstration of confidence that they could address all the issues.
The SP, all things considered, has remained remarkably stable since the initial CRL sell off. Having said that, I am admittedly getting a bit impatient for an RNS to confirm the resubmission as we are rapidly approaching the six month mark. Hopefully something soon.

Lol Etot, the style of Mulder’s posts reminded me of Manuel in Fawlty Towers. Is good English no?

I agree Bazz, the spread is ridiculous. It’s hard to tell if it really is that high because, obviously, I can’t sell. The lse spread for ORPH, for example, is showing as 7.41%. A £2k dummy buy and sell trade of OO on HL and the actual spread is really 3%.
So basically I don’t know how accurate the stated POLB spread really is?

I agree B009, and it has been suggested before on this board. Sadly, it seems, Soup has not applied yet for the role.
Come on Soup, your efforts, due diligence and research are fantastic. Judging by the previous CEO’s it wouldn’t take up much of your time :)

Sorry, I know this is the wrong board, but there has been no reaction to today’s RNS on the POLB board.
I thought it was good news & JS has been on VOX markets, if anyone is interested.
https://audioboom.com/posts/8053679-jeremy-skillington-of-poolbeg-pharma-discusses-their-deal-with-cytoreason-a-leading-ai-company

https://audioboom.com/posts/8053679-jeremy-skillington-of-poolbeg-pharma-discusses-their-deal-with-cytoreason-a-leading-ai-company

Fair play to JS, as he says, they are executing on strategy. I think they have done great in a very short space of time. Whether that will be reflected in the SP is another matter, especially when the lock in period expires.
As JS points out CytoReason are a big league player who deal with the major pharma companies, so we are moving all the right circles.

Si, that comment intrigued me too.

There were a few nuggets from the meeting ref the spin outs, for example -

Ref Wally’s notes “Is DIM difficult to spin off? If yes, why not put into a subsidiary company??- Good point, watch this space, DIM might move sooner than expected”. I found that a very interesting comment. Any ideas what that might entail? I am trying to read up about spin outs and the benefit of subsidiaries to shareholders.

“Are you mitigating perceived overhang at the end of POLB lockup??- POLB may be in a position to use some of its cash balance to buy back shares or pay a dividend - we are not doing this in ORPH as we have vastly bigger liquidity whereas POLB has tiny daily volume, so a buyback is more logical in terms of driving the share price up; this would not be possible with ORPH.
ORPH has ‘very good plans and ideas’ for our cash - ‘trust us with it, we’re not burning through it’ - news to come”.
At a previous webinar JS had seemed surprised at a question asking him if he thought the SP would weaken on a potential exodus at the end of the lock out. I am glad the potential problem has been recognised and will hopefully be mitigated to an extent by a share buyback.

I thought it a very informing meeting and renewed my optimism in the company. My thanks too WALLY for the excellent notes, they are a great transcript and I often refer the them.

Yes, it’s a big club Jiving with no membership perks. I think it’s a very safe bet to say that no one on here will be in positive territory.

Evening Shandy, a good and fair post and I agree with you.
CF has made some ill judged comments but I don’t doubt his motivation or his intelligence. I also appreciate the time he gives to investors and the substantial investment he has made in the company.
Like you I am holding because of the growth of the core business. I did fall for some of CF’s hype regarding the spin offs, but I am intrigued (I can’t think of a better word) what the eventual outcome will be. Nobody can accuse ORPH of being dull. ATB

With respect Shandy & DS, whilst “promise” may not technically be the correct word, CF has definitely intimated/guided on a number of occasions expected timelines that have been missed my miles.
I am not a deramper. The core business is very solid. But CF has, unfortunately, created a bit of a rod for his own back with his overly ambitious targets.

I enjoyed last nights meeting, I thought there was a lot of positives. Upwards and onwards and happy to hold.

Thanks Wally, brilliant summary again. I did listen to the webinar but I have very flakey internet tonight and it kept cutting out on all the interesting questions. Thanks for filling in the gaps on what I thought was a very positive presentation. Interesting that CF may consider a POLB share buyback to bolster the SP when the lockup expires. Many thanks again.

It’s great to see a decent (and hopefully sustained) bounce after CF and Mo’s presentation. It definitely seems to have reassured the market.

“BTW, had the original plan played out, ORPH would have smashed FY 2021 forecast.” True, but equally if CF’s original plan/guidelines had played out all the spin outs would have completed by Christmas 2020.
But I take your point regarding the core business, which is very solid and obviously some variables are completely out of CF’s control.

Agreed Kaiver, Donald is a good bloke but I don’t think Sarah Lowther would have been so diplomatic. Any questions with any criticism were swept into one general one, it was almost comical. I thought Mo came over well.
Thanks Wally, you are a genius note taker.
CF - I look forward to the “surprise & delight” with the excess cash.

Hi Shandypants, I took “difficult markets conditions” as a fairly general comment to refer to the SP and the wider AIM market being out of favour?
Hopefully the no spin out mention is part of the new under promise strategy? I would expect them to be definitely discussed this evening, in the question section at the very least.
Perhaps in hindsight 40p at the time was a bit frothy but the adverse market reaction of the last 10 months seems crazy and undeserved imo. I am looking forward to tonight’s meeting. ATB

The continuing worry is that sentiment is so poor that whatever good news we get the SP won’t move in the right direction. We are an expanding, EBITDA positive business in a growth area with high quality customers who give us repeat orders, it is very frustrating.

With respect Russky, ORPH has been dropping like a stone for months and it’s loss way outstrips the the FTSE Aim All-Share index.
ORPH year range -78%
FTSE Aim All-Share index year range -28.32%
Agree totally that it’s not another Rob Terry and that other shares have also been hit by the Ukraine crisis. Unfortunately our losses have been particularly bad for a more prolonged period.

I think out of all the meetings CF has given tomorrow’s, for me, will be the most important. I appreciate that CF can’t say anything that requires to be RNS’d, but I am interested to see what CF’s views are on the SP, progress on the spin outs , general outlook etc.
Question from me will be about the possibility a of share buyback/dividend. GLA